Matches in SemOpenAlex for { <https://semopenalex.org/work/W201439419> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W201439419 endingPage "73, 456" @default.
- W201439419 startingPage "369" @default.
- W201439419 abstract "Minor depression is reported in 20-60% of schizophrenic patients during various stages of their disorders; impairing patients' compliance, response to treatment and worsening their overall prognosis. Various anti-depressive treatments have been proposed for such cases but response rates are usually poor. Pyridoxine (Vitamin B6) in essential for the proper metabolism of various neurotransmitters that are considered relevant to the pathophysiology of depression and/or schizophrenia and it has been reported beneficial in ameliorating depressive symptoms as part of major depression, premenstrual syndrome or 'Chinese restaurant syndrome'. We hypothesized that addition of pyridoxine to on-going neuroleptic treatment could improve minor depression in schizophrenic patients.Nine schizophrenic patients with co-morbid minor depression participated in this study. All participants had a stable unchanged clinical state (changes in Brief Psychiatric Rating Scale (BPRS). Scale for the Assessment of Positive Symptoms (SAPS), and Scale for the Assessment of Negative symptoms (SANS) scores < 5%) and all were maintained on unchanged doses of anti-psychotic drugs for at least 4 consecutive weeks prior to initiation of the study. Participants received, open-label, pyridoxine 150 mg/day in addition to their anti-psychotic treatment for 4 consecutive weeks. Mental status was evaluated before, during, and at the end of 4 weeks of pyridoxine administration using the BPRS, SAPS, SANS and HAM-D.Two of the nine patients (22%), characterized by higher initial HAM-D and SANS scores, and by older age and longer duration of illness, experienced marked improvements in depressive symptoms (23% and 28% decrease in HAM-D scores) following 4 weeks of pyridoxine administration. In one of these two, the improvement in depressive symptoms was accompanied by a parallel decrease in SANS Scores.A subgroup of schizophrenic patients with comorbid minor depression may benefit from pyridoxine addition to their on-going anti-psychotic treatment." @default.
- W201439419 created "2016-06-24" @default.
- W201439419 creator A5002078296 @default.
- W201439419 creator A5018959846 @default.
- W201439419 creator A5039512062 @default.
- W201439419 creator A5052298362 @default.
- W201439419 creator A5074192515 @default.
- W201439419 date "2001-05-01" @default.
- W201439419 modified "2023-09-23" @default.
- W201439419 title "[Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial]." @default.
- W201439419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11419053" @default.
- W201439419 hasPublicationYear "2001" @default.
- W201439419 type Work @default.
- W201439419 sameAs 201439419 @default.
- W201439419 citedByCount "4" @default.
- W201439419 countsByYear W2014394192016 @default.
- W201439419 crossrefType "journal-article" @default.
- W201439419 hasAuthorship W201439419A5002078296 @default.
- W201439419 hasAuthorship W201439419A5018959846 @default.
- W201439419 hasAuthorship W201439419A5039512062 @default.
- W201439419 hasAuthorship W201439419A5052298362 @default.
- W201439419 hasAuthorship W201439419A5074192515 @default.
- W201439419 hasConcept C118552586 @default.
- W201439419 hasConcept C126322002 @default.
- W201439419 hasConcept C139719470 @default.
- W201439419 hasConcept C162324750 @default.
- W201439419 hasConcept C2776412080 @default.
- W201439419 hasConcept C2776514930 @default.
- W201439419 hasConcept C2776867660 @default.
- W201439419 hasConcept C2778528637 @default.
- W201439419 hasConcept C2779727114 @default.
- W201439419 hasConcept C2780442968 @default.
- W201439419 hasConcept C71924100 @default.
- W201439419 hasConceptScore W201439419C118552586 @default.
- W201439419 hasConceptScore W201439419C126322002 @default.
- W201439419 hasConceptScore W201439419C139719470 @default.
- W201439419 hasConceptScore W201439419C162324750 @default.
- W201439419 hasConceptScore W201439419C2776412080 @default.
- W201439419 hasConceptScore W201439419C2776514930 @default.
- W201439419 hasConceptScore W201439419C2776867660 @default.
- W201439419 hasConceptScore W201439419C2778528637 @default.
- W201439419 hasConceptScore W201439419C2779727114 @default.
- W201439419 hasConceptScore W201439419C2780442968 @default.
- W201439419 hasConceptScore W201439419C71924100 @default.
- W201439419 hasIssue "5" @default.
- W201439419 hasLocation W2014394191 @default.
- W201439419 hasOpenAccess W201439419 @default.
- W201439419 hasPrimaryLocation W2014394191 @default.
- W201439419 hasRelatedWork W191018927 @default.
- W201439419 hasRelatedWork W2002562483 @default.
- W201439419 hasRelatedWork W2002687749 @default.
- W201439419 hasRelatedWork W2007578358 @default.
- W201439419 hasRelatedWork W2113886123 @default.
- W201439419 hasRelatedWork W2133434159 @default.
- W201439419 hasRelatedWork W2142451645 @default.
- W201439419 hasRelatedWork W3080633129 @default.
- W201439419 hasRelatedWork W4286719116 @default.
- W201439419 hasRelatedWork W2186723263 @default.
- W201439419 hasVolume "140" @default.
- W201439419 isParatext "false" @default.
- W201439419 isRetracted "false" @default.
- W201439419 magId "201439419" @default.
- W201439419 workType "article" @default.